Accueil > Actualité
Actualite financiere : Actualite bourse

Novo Nordisk: Stifel trims TP

(CercleFinance.com) - Stifel maintains its Buy rating on Novo Nordisk shares, with a target price trimmed from 960 DKK to 950 DKK.


The analyst reports that Novo Nordisk's share price was very volatile yesterday, due to mixed quarterly results and a less clear short-term outlook.

The broker thinks that yesterday's events could give investors the impression that the investment case is becoming more complex.

Stifel reports that this is the first time in two years that it has not raised its figures after a quarterly report.

With the relatively binary results of Mim8's AdCom and icodec still to come, we think it wise to recommend some diversification in the European pharmaceutical universe, the broker concludes.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.